ERYtech Pharma Strengthens Its Intellectual Property Portfolio
LYON, France--(BUSINESS WIRE)--Regulatory News:
ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, announces the granting of two key patents for its core product ERY-ASP.
Help employers find you! Check out all the jobs and post your resume.